NOT-HL-17-492: Notice of Intent to Publish a Funding Opportunity Announcement for Implementation Research for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U34)

Notice of Intent to Publish a Funding Opportunity Announcement for Implementation Research for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U34)

Notice Number: NOT-HL-17-492

Key Dates
Release Date: March 9, 2017

Estimated Publication Date of Announcement: June 2017
First Estimated Application Due Date: October 2017
Earliest Estimated Award Date: July 2018
Earliest Estimated Start Date: August 2018

Related Announcements
NOT-HL-17-493

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The National Heart, Lung and Blood Institute (NHLBI) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) which will support implementation research for heart, lung, blood, and sleep (HLBS) diseases in the acute care hospital setting. This FOA proposes to support planning activities for hybrid effectiveness-implementation trials in the inpatient setting.

This Notice is being provided to allow potential applicants sufficient time to develop responsive projects.

The FOA is expected to be published in June 2017 with an anticipated application receipt date in October 2017.

This FOA will utilize the U34 activity code. Details of the planned FOA are provided below.

Research Initiative Details

The intended FOA will seek applications to support planning activities for hybrid effectiveness-implementation trials to evaluate the effect of an implementation strategy aimed at increasing provider adherence to an evidence-based practice(s) on implementation and clinical outcomes.

Applicants will be required to have a multidisciplinary research team that includes both inpatient clinical research expertise and implementation research expertise.

At the conclusion of the U34, awardees and other qualified applicants will be eligible to apply for the subsequent U01 grant which will support the trial.

APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.

Inquiries

Please direct all inquiries to:

Lora Reineck, MD, MS
Division of Lung Diseases
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0222
Email: lora.reineck@nih.gov

Catherine Stoney, PhD
Division of Cardiovascular Sciences
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-435-6670
Email: stoneyc@nhlbi.nih.gov

Cheryl Boyce, PhD
Center for Translation Research and Implementation Science
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-496-1051
Email: cheryl.boyce@nih.gov

Andrei Kindzelski, MD, PhD
Division of Blood Diseases and Resources
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-435-0050
Email: kindzelskial@nhlbi.nih.gov